Materials & Resources » Chemicals | Miwon Commercial Co. Ltd.

Miwon Commercial Co. Ltd. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
235,226
247,219
239,437
242,966
318,656
328,648
Cost of Goods Sold (COGS) incl. D&A
196,290
210,684
200,912
202,680
281,010
276,066
Gross Income
38,936
36,535
38,525
40,287
37,645
52,582
SG&A Expense
20,663
18,644
19,881
23,242
26,306
25,173
EBIT
18,127
17,727
18,451
-
10,997
27,172
Unusual Expense
62
1,753
71
101
3
15,408
Non Operating Income/Expense
1,500
1,717
1,864
7,494
18,001
10,132
Interest Expense
1,635
1,541
966
348
525
512
Pretax Income
18,071
16,316
19,703
26,006
31,083
26,041
Income Tax
2,817
5,543
4,379
4,796
4,463
1,827
Equity in Affiliates
835
902
1,647
-
-
-
Consolidated Net Income
16,089
11,675
16,971
21,209
26,619
24,215
Net Income
13,723
9,831
14,288
17,581
24,245
21,530
Net Income After Extraordinaries
13,723
9,831
14,288
13,303
21,271
21,530
Net Income Available to Common
13,723
9,831
14,288
21,858
27,219
21,530
EPS (Basic)
15,731.00
11,324.00
16,383.00
25,254.00
32,509.00
4,291.95
Basic Shares Outstanding
1
1
1
1
1
5
EPS (Diluted)
15,731.47
11,323.76
16,382.81
25,254.21
32,509.41
4,291.94
Diluted Shares Outstanding
1
1
1
1
1
5
EBITDA
30,299
31,636
32,264
32,033
32,295
41,905
Other Operating Expense
146
164
193
343
343
237
Non-Operating Interest Income
141
166
166
172
198
274
Minority Interest Expense
2,366
1,844
2,683
3,629
2,374
2,685
Equity in Affiliates (Pretax)
-
-
-
1,832
2,344
4,129

About Miwon Commercial Co.

View Profile
Address
49 Wonsi-ro
Ansan GY 15610
Korea, Republic Of
Employees -
Website http://www.mwc.co.kr
Updated 07/08/2019
Miwon Commercial Co., Ltd. engages in the manufacture of chemicals such as sulfuric acid and sulfur powder. It operates through following business areas: Personal Care Ingredients, Electronic Chemicals, and Polymer Additives. The Personal Care Ingredients business provides surfactants, conditioning polymers, styling resin, cosmeceutical active ingredients, and others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.